Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by BuddingInvestoron Apr 01, 2018 4:27pm
171 Views
Post# 27812325

RE:Germany ?

RE:Germany ?
Vinny57 wrote: Is it not funny that some on this board will post out and out lies and mistruths ( not to mension the vugarities ) yet critisize someone because of the odd spelling mistake? ( I do not use Spellcheck ) Anyways; The setback with the German LPs should be small potatoes.  Again, it will just take more time.(Just more bad news.)


Correct me if I'm wrong but doesn't the NUU deal bring with it 13,000 pharmacies to supply.
Bullboard Posts